Sweden preventive healthcare startup Neko Health raised $700 million in Series C funding at $7 billion valuation, founded in 2018 by Daniel Ek (Spotify co-founder) & Hjalmar Nilsonne. Jul 17, 2026 17th July 2026 | Hong Kong Sweden preventive healthcare startup Neko Health has raised $700 million in Series C funding at $7 billion valuation. Neko Health was founded in 2018 by Daniel Ek (Spotify co-founder) & Hjalmar Nilsonne. Neko Health - Neko Health is a health technology company that opened its first clinic in Stockholm in 2023, founded by Daniel Ek and Hjalmar Nilsonne. Neko Health designs and engineers its own hardware, software, and clinical protocols in-house, powering a one-hour full-body Neko Health Scan delivered across clinics in Stockholm, London, Manchester and Birmingham. Neko Health is expanding to the United States in 2026. "Sweden preventive healthcare startup Neko Health raised $700 million in Series C funding at $7 billion valuation, founded in 2018 by Daniel Ek (Spotify co-founder) & Hjalmar Nilsonne"

Whole-body imaging firm Neko Health raises $700M. Neko Health founders Daniel Ek (left) and Hjalmar Nilsonne pose in front of the company's "new medical scanning technology concept." Neko Health Neko Health, a whole-body imaging firm co-founded by Spotify CEO Daniel Ek, has raised $700 million in funding. First launched in Sweden in 2023, Neko differs from other imaging startups such as Prenuvo in that it does not use MRI. Rather, the company deploys a "comprehensive," radiation-free scanner that uses proprietary sensors to assess patient health. Neko says it has seen strong demand since its launch, with over 100,000 scans delivered in the U.K. and Sweden and 350,000 individuals on its waitlist. Lightspeed and O.G. Venture Partners led the Series C financing round with participation from several others. Ek, a billionaire Swedish entrepreneur behind the popular music streaming service, and colleagues said they'll use the funds to scale the business, with the first U.S. location coming soon. "This funding is a strong vote of confidence in what we set out to do when we opened our first clinic three years ago: a completely new healthcare experience designed to keep people healthy, catch problems early and help prevent disease before it even starts," Hjalmar Nilsonne, Neko Health CEO and co-founder, said in a July 15 announcement. "With this round, we're taking that mission to the U.S. for the first time, while continuing to invest in the research and technology that make prevention possible at scale." Multiple other VC firms also participated in the fundraising round, alongside celebrities such as musician Wil.i.am, Facebook co-founder Mark Zuckerberg, and former tennis star Maria Sharapova. As part of the agreement, David Ofer, with O.G. Venture Partners, will join the board of directors, subject to regulatory approval. This follows a previous $260 million Series B fundraising round in January 2025. Neko Health charges between $300 to $400 (USD) for its 60-minute scans in the U.K. and Sweden. The noninvasive assessment uses blood analysis and its own imaging sensors to capture "millions" of health data points. Neko said its scan evaluates skin health (including moles and marks), biomarkers to identify signs of pre-diabetes, blood abnormalities and risk factors linked to metabolic syndrome, stroke and heart attack. Results are delivered on-site within minutes and discussed in-person with a medical professional, "providing members personalized and actionable health findings." The funding announcement comes weeks after Neko also added body composition measures to its service, along with having clinicians review data from wearables. These add-ons are now live across all clinics, "giving members an even more detailed picture of their health." "This is the latest step in a program of continuous innovation, made possible by Neko owning every part of its tech stack in-house," the company said in its announcement. "This vertical integration is not incidental; it is the foundation that allows Neko Health to control the experience from start to finish, to move faster and to improve continuously," it added later. Since the company launched in 2023, Neko has expanded its footprint across the U.K., with outposts in Manchester, Birmingham and London, alongside a new outpost in Sweden launched last month. About 75% of members now book and prepay for scans for the following year, Neko estimated. "Over the past 18 months, Neko Health has demonstrated remarkable innovation and growth, attacking one of the largest markets in the world with breakthrough technology, proven consumer demand, and a clear path to global scale," Bejul Somaia, global partner with Menlo Park, California-based Lightspeed Venture Partners, said in a statement. "We believe this is one of the most important healthcare companies of our generation, and we're proud to deepen our partnership as they continue to reimagine prevention." The announcement comes amid growing interest in these preventive imaging scans for healthy people. AI lab Midjourney last month announced it was investing over $74 million to launch its own whole-body scanning chain with plans for the first location in San Francisco later this year. Marty Stempniak Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.

Neko Health raises $700m as US market entry draws closer. Neko Health is planning to open its first US site in New York, with further US sites to follows, this year. Neko Health has raised $700m, setting the company up with proceeds to scale its full-body scanning service ahead of the planned launch of its first US clinics this year. Putting its funds raised to date at over $1bn, Neko's Series C financing round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. New backers include Liberty City Ventures and Positive Sum, while individual investors, such as Meta CEO Mark Zuckerberg and former footballer Thierry Henry, also participated. Co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek - who is also the former CEO of music app Spotify - the health tech startup's non-invasive Neko Health Scan diagnostic uses 70 scanners and a combination of technologies, including thermal imaging and 2D/3D photography, to map approximately 50 million health data points in a user's body. Neko has attracted considerable interest among Europe's health tech scene since launching its first clinic in Stockholm, Sweden, in 2023. From there, the company launched its first UK site in Marylebone, London, in September 2024, and has since expanded its UK operations with three additional sites in London and one in Birmingham and Manchester. Users attend one of Neko's clinics and enter a chamber-like room. What follows is a 60-minute health assessment, priced at £299 in the UK and 2,750 SEK in Sweden. Throughout the session, vectors including skin health and metabolic composition are assessed, with biomarkers used to identify pre-diabetes risk, potential blood abnormalities, and risk factors linked to pathologies including metabolic syndrome, stroke, and heart attack. Patient's recieve most results from the scan during a consultation immediately afterwards. Neko has also recently added what it calls its "most significant" scan advancement to date. Now available at all existing clinics, the addition of body composition measures and clinician review of wearable data is designed to "give members an even more detailed picture of their health" in the moment and between visits, the company stated. Concluding a $260m Series B fundraise in January 2025, Neko's latest and largest fundraise to date, serves as ample testament to the ongoing demand for its services. According to Neko, over 350,000 people have joined the waitlist or registered for a Neko Health Scan, while more than 100,000 in the UK and Sweden have already experienced one. Hiring Dr Sunita Mishra as chief medical officer (CMO) in March 2026, who previously served as CMO at Amazon Health, Neko is now eyeing expansion into the US, with its first site due to launch in New York this year. Neko's co-founder and CEO, Hjalmar Nilsonne, said: "This funding is a strong vote of confidence in what Medical Device Network set out to do when Medical Device Network opened its first clinic three years ago: a completely new healthcare experience designed to keep people healthy, catch problems early and help prevent disease before it even starts. "With this round, we're taking that mission to the US for the first time, while continuing to invest in the research and technology that make prevention possible at scale." Give your business an edge with its leading industry insights.